SCHEMBL7913259

SCHEMBL7913259

Fc1ccc(-c2nnc(Nc3cccc(C(F)(F)F)c3)c3ccccc23)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 1/20 0.63
MAPT P10636 5/20 0.59
KDR P35968 4/20 0.57
NPSR1 Q6W5P4 2/20 0.57
ABCG2 Q9UNQ0 5/20 0.57
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 1/20 0.55
PDE5A O76074 1/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
HPGD P15428 1/20 0.55
ALOX15 P16050 1/20 0.55
CYP2C19 P33261 1/20 0.55
PDE1A P54750 1/20 0.55
PDE1B Q01064 1/20 0.55
PDE3B Q13370 1/20 0.55
PDE1C Q14123 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8014060 0.91 MAPT (0.66) CA9MAPTKDRNPSR1ABCG2
SCHEMBL7905464 0.89 MAPT (0.63) CA9MAPTKDRNPSR1SMN1; SMN2
SCHEMBL7914888 0.89 MAPT (0.64) CA9MAPTKDRNPSR1ABCG2
SCHEMBL7913328 0.86 KDR (0.69) CA9MAPTKDRNPSR1ABCG2
SCHEMBL7904950 0.85 KDR (0.66) CA9MAPTKDRNPSR1ABCG2
SCHEMBL7914924 0.83 NPSR1 (0.73) MAPTKDRNPSR1SMN1; SMN2KDM4E
SCHEMBL788243 0.82 KDR (0.66) CA9MAPTKDRNPSR1LMNA
SCHEMBL7912120 0.82 MAPT (0.59) CA9MAPTKDRNPSR1ABCG2
SCHEMBL7913391 0.82 MAPT (0.81) MAPTKDRNPSR1ABCG2SMN1; SMN2
SCHEMBL7905052 0.82 MAPT (0.58) CA9MAPTKDRNPSR1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed